Christopher DeRenzo

1.5k total citations
24 papers, 638 citations indexed

About

Christopher DeRenzo is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Christopher DeRenzo has authored 24 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Christopher DeRenzo's work include CAR-T cell therapy research (21 papers), Virus-based gene therapy research (10 papers) and Nanowire Synthesis and Applications (6 papers). Christopher DeRenzo is often cited by papers focused on CAR-T cell therapy research (21 papers), Virus-based gene therapy research (10 papers) and Nanowire Synthesis and Applications (6 papers). Christopher DeRenzo collaborates with scholars based in United States, Japan and Germany. Christopher DeRenzo's co-authors include Stephen Gottschalk, Jessica Wagner, Elizabeth Wickman, Giedre Krenciute, Dalia Haydar, Phuong Nguyen, Zhongzhen Yi, Peter Vogel, Timothy I. Shaw and Jason Chiang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Christopher DeRenzo

24 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher DeRenzo United States 12 541 249 172 172 122 24 638
Vita S. Salsman United States 6 535 1.0× 279 1.1× 154 0.9× 159 0.9× 156 1.3× 9 660
Slava Stamova Germany 13 617 1.1× 388 1.6× 146 0.8× 163 0.9× 91 0.7× 22 752
Parisa Malekzadeh United States 7 651 1.2× 377 1.5× 150 0.9× 196 1.1× 101 0.8× 14 795
Alexia Ghazi United States 7 498 0.9× 193 0.8× 215 1.3× 202 1.2× 191 1.6× 11 674
Tatsunori Goto Japan 14 435 0.8× 240 1.0× 163 0.9× 216 1.3× 146 1.2× 48 723
Sanfang Tu China 16 582 1.1× 201 0.8× 144 0.8× 297 1.7× 154 1.3× 52 858
Kathleen Gallagher United States 12 633 1.2× 195 0.8× 212 1.2× 196 1.1× 151 1.2× 32 837
Stefanie Lesch Germany 8 686 1.3× 278 1.1× 211 1.2× 284 1.7× 188 1.5× 10 798
Erik F. Williams United States 3 388 0.7× 224 0.9× 105 0.6× 170 1.0× 76 0.6× 4 556
Sunil S. Raikar United States 13 405 0.7× 252 1.0× 79 0.5× 205 1.2× 111 0.9× 37 639

Countries citing papers authored by Christopher DeRenzo

Since Specialization
Citations

This map shows the geographic impact of Christopher DeRenzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher DeRenzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher DeRenzo more than expected).

Fields of papers citing papers by Christopher DeRenzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher DeRenzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher DeRenzo. The network helps show where Christopher DeRenzo may publish in the future.

Co-authorship network of co-authors of Christopher DeRenzo

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher DeRenzo. A scholar is included among the top collaborators of Christopher DeRenzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher DeRenzo. Christopher DeRenzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talbot, Lindsay J., Alexandra Beckett, Phuong Nguyen, et al.. (2024). Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models. Clinical Cancer Research. 30(19). 4434–4449. 11 indexed citations
2.
Epperly, Rebecca, Stephen Gottschalk, & Christopher DeRenzo. (2024). CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives. SHILAP Revista de lepidopterología. 3. 100160–100160. 7 indexed citations
3.
Smith, Kyle, Deanna Langfitt, Stephen Gottschalk, et al.. (2024). Abstract PR014: Robust disease monitoring using CSF liquid biopsies collected from children undergoing cellular therapy for malignant central nervous system tumors. Clinical Cancer Research. 30(21_Supplement). PR014–PR014. 1 indexed citations
4.
5.
Haydar, Dalia, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.. (2023). CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity. Cancer Research Communications. 3(12). 2430–2446. 10 indexed citations
6.
Akel, Salem, Jeoung-Eun Park, Fei Zheng, et al.. (2023). Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axis. Cytotherapy. 25(11). 1149–1154. 2 indexed citations
7.
Adeshakin, Adeleye O., Peipei Zhou, Jean‐Yves Métais, et al.. (2023). Abstract 1778: B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion. Cancer Research. 83(7_Supplement). 1778–1778. 1 indexed citations
8.
Beckett, Alexandra, Peter Chockley, Shondra M. Pruett‐Miller, et al.. (2023). CD47 expression is critical for CAR T-cell survival in vivo. Journal for ImmunoTherapy of Cancer. 11(3). e005857–e005857. 19 indexed citations
9.
Talbot, Lindsay J., Phuong Nguyen, Jessica Wagner, et al.. (2021). A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells. Frontiers in Immunology. 12. 691741–691741. 20 indexed citations
10.
DeRenzo, Christopher & Stephen Gottschalk. (2020). Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s. Advances in experimental medicine and biology. 1257. 109–131. 8 indexed citations
11.
Wagner, Jessica, Elizabeth Wickman, Christopher DeRenzo, & Stephen Gottschalk. (2020). CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?. Molecular Therapy. 28(11). 2320–2339. 257 indexed citations
12.
Nguyen, Phuong, Emmanuel Sunday Okeke, Michael R. Clay, et al.. (2020). Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells. Molecular Therapy — Oncolytics. 18. 202–214. 42 indexed citations
13.
DeRenzo, Christopher & Stephen Gottschalk. (2019). Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors. Frontiers in Immunology. 10. 218–218. 39 indexed citations
14.
DeRenzo, Christopher, Catherine G. Lam, Carlos Rodríguez‐Galindo, et al.. (2018). Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma. Pediatric Blood & Cancer. 66(1). e27469–e27469. 6 indexed citations
15.
DeRenzo, Christopher, Giedre Krenciute, & Stephen Gottschalk. (2018). The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid Tumors. American Society of Clinical Oncology Educational Book. 38(38). 830–837. 24 indexed citations
16.
Hegde, Meenakshi, Christopher DeRenzo, Huimin Zhang, et al.. (2017). Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma.. Journal of Clinical Oncology. 35(15_suppl). 10508–10508. 34 indexed citations
17.
DeRenzo, Christopher. (2016). Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update. Journal of Clinical & Cellular Immunology. 7(2). 2 indexed citations
18.
DeRenzo, Christopher & Stephen Gottschalk. (2014). Genetically Modified T-Cell Therapy for Osteosarcoma. Advances in experimental medicine and biology. 804. 323–340. 13 indexed citations
19.
Krebs, Simone, Tania Rodríguez-Cruz, Christopher DeRenzo, & Stephen Gottschalk. (2013). Genetically Modified T Cells to Target Glioblastoma. Frontiers in Oncology. 3. 322–322. 13 indexed citations
20.
Lin, Siang-Yo, Sonia Dolfi, Sohrab Amiri, et al.. (2013). P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms. International Journal of Oncology. 43(6). 1817–1823. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vita S. Salsman Breakdown of academic impact, for papers by Slava Stamova Breakdown of academic impact, for papers by Parisa Malekzadeh Breakdown of academic impact, for papers by Alexia Ghazi Breakdown of academic impact, for papers by Tatsunori Goto Breakdown of academic impact, for papers by Sanfang Tu Breakdown of academic impact, for papers by Kathleen Gallagher Breakdown of academic impact, for papers by Stefanie Lesch Breakdown of academic impact, for papers by Erik F. Williams Breakdown of academic impact, for papers by Sunil S. Raikar
Rankless by CCL
2026